<TABLE>
<CAPTION>
<S> <C>
----------------------------------
UNITED STATES OMB APPROVAL
----------------------------------
----------------------------------
SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0145
WASHINGTON, D.C. 20549 Expires:December 31, 1997
Estimated average burden
hours per response 14.90
----------------------------------
</TABLE>
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)*
Arterial Vascular Engineering, Inc.
-----------------------------------------
(Name of Issuer)
Common Stock
-----------------------------------------
(Title of Class of Securities)
043013-10-1
-----------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ]. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class securities
described in Item 1; and (2) has filed no amendment subsequent thereto reporting
beneficial ownership of five percent or less of such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
1.
<PAGE>
<TABLE>
<CAPTION>
<S> <C> <C>
- ----------------------------------------------------- ------------------------------------------
CUSIP No. 043013-10-1 13G Page 2 of 4 Pages
-------------------------
- ----------------------------------------------------- ------------------------------------------
- ------------- ----------------------------------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS
Bradly A. Jendersee; S.S.N. ###-##-####
- ------------- ----------------------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
Not Applicable (b) [ ]
- ------------- ----------------------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------- ----------------------------------------------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- ---------------------------- ------- -----------------------------------------------------------------------------------------------
5 SOLE VOTING POWER
1,947,864*
NUMBER OF
------- -----------------------------------------------------------------------------------------------
SHARES BENEFICIALLY OWNED 6 SHARED VOTING POWER
BY 0
------- -----------------------------------------------------------------------------------------------
EACH REPORTING PERSON WITH 7 SOLE DISPOSITIVE POWER
1,947,864*
------- -----------------------------------------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
- ------------- ----------------------------------------------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,947,864*
- ------------- ----------------------------------------------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
- ------------- ----------------------------------------------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.2%
- ------------- ----------------------------------------------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- ------------- ----------------------------------------------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
</TABLE>
2.
<PAGE>
<TABLE>
<CAPTION>
<S> <C> <C>
ITEM 1.
(a) Name of Issuer: Arterial Vascular Engineering, Inc.
(b) Address of Issuer's Principal Executive Offices: 3576 Unocal Place
Santa Rosa, CA 95403
ITEM 2.
(a) Name of Person Filing: Bradly A. Jendersee
(b) Address of Principal Business Office: 4185 Creciente Dr.
Santa Barbara, CA 93110
(c) Citizenship: United States
(d) Title of Class of Securities: Common Stock
(e) CUSIP Number: 043013-10-1
ITEM 3. Not Applicable
ITEM 4. Ownership:
(a) Amount Beneficially Owned: 1,947,864*
(b) Percent of Class: 6.2%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 1,947,864*
(ii) shared power to vote or to direct the vote: 0
(iii) sole power to dispose or to direct the disposition of: 1,947,864*
(iv) shared power to dispose or to direct the disposition of: 0
<FN>
* Includes 184,625 shares held by family trusts for which Shelley A. Duane
(Mr. Jendersee's mother) and J.P. Morgan California are co-trustees and as
to which shares Mr. Jendersee disclaims beneficial ownership.
</FN>
</TABLE>
ITEM 5. Ownership of Five Percent or Less of a Class:
Not Applicable
3.
<PAGE>
ITEM 6. Ownership of More than Five Percent on Behalf of Another Person:
Not Applicable
ITEM 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company:
Not Applicable
ITEM 8. Identification and Classification of Members of the Group:
Not Applicable
ITEM 9. Notice of Dissolution of Group:
Not Applicable
ITEM 10. Certification:
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true,
complete and correct.
February 12, 1998
----------------------------------
Date
/s/ Bradly A. Jendersee
----------------------------------
Bradly A. Jendersee
4.
